Product Description
Dapoxetine Hydrochloride 30mg Tablets: What the Published Guidance Says
PDE5 inhibitors and premature-ejaculation treatments supplied to the same documentation standard as the rest of our range, for markets where these products are registered.
Dapoxetine Hydrochloride 30mg Tablets is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Sexual Health range overview.
- What we verify before dispatch Each batch is released against its certificate of analysis covering assay, related substances and dissolution. Container-closure and stability data are supplied with the dossier package, together with registration support documents for national filings.
- A category where documentation is the differentiator Products in this category are frequently targeted by counterfeiters and are heavily regulated in most markets. The procurement priority is therefore not price per tablet but verified assay, dissolution equivalence and traceable batch documentation from a manufacturer you can audit.
- Why the WHO Model List is narrow by design WHO selects essential medicines on public health relevance, evidence of benefits and harms, and with consideration of costs, affordability and other relevant factors. The Model List represents only a small proportion of the medicines available globally and is revised every two years through an evidence-based process. We therefore do not present list status as supporting evidence for the products in this group — the analytical and documentation standard is the argument, and that is what a regulator will assess. WHO — Essential medicines (fact sheet)
These points are quoted because they shape how Dapoxetine Hydrochloride 30mg Tablets is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Dapoxetine Hydrochloride 30mg Tablets — Supply Parameters
| Product Name | Dapoxetine Hydrochloride Tablets (Dapoxetine Hydrochloride 30mg Oral Tablets) |
| Specification | Each tablet contains: Dapoxetine Hydrochloride 30mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Dapoxetine Hydrochloride |
| Pharmacological Class | Short-Acting Selective Serotonin Reuptake Inhibitor (SSRI) |
| Route of Administration | Oral administration (swallowed whole with water). Take 1 to 3 hours before anticipated sexual activity. Do not take more than one dose in 24 hours. |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Therapeutic group | Sexual Health — Sexual Health |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Tadalafil 20mg + Dapoxetine 30mg Tablets, Tadalafil Tablets 20mg, Vardenafil 20mg Tablets.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Dapoxetine Hydrochloride 30mg Tablets is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 3 or 6 tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
This page describes Dapoxetine Hydrochloride 30mg Tablets as a product of the sexual and reproductive health medicines named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Frequently Asked Questions
What pack size is available for Dapoxetine Hydrochloride 30mg Tablets?
The reference pack is Blister pack (PVC-Alu) or HDPE bottle, typically 3 or 6 tablets per blister pack or bottle. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.
What documentation comes with a shipment of Dapoxetine Hydrochloride 30mg Tablets?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Dapoxetine Hydrochloride 30mg Tablets support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which products do you supply in this category?
Vardenafil 20 mg, tadalafil 20 mg, dapoxetine 30 mg and a tadalafil/dapoxetine compound tablet.
Do you cite WHO listing for these products?
No. We do not use WHO Model List status as supporting evidence in this category. The Model List is deliberately narrow — WHO includes medicines selected on public health relevance, evidence of benefits and harms, and cost — and the argument for these products is the analytical and documentation standard instead.
Related Sexual Health Products
- Tadalafil 20mg + Dapoxetine 30mg Tablets — 20mg
- Tadalafil Tablets 20mg — 20mg
- Vardenafil 20mg Tablets — 20mg
Browse the full Sexual Health range; all Tablets; the complete product catalogue.
Request a Quotation for Dapoxetine Hydrochloride 30mg Tablets
Send the specification, pack size, quantity and destination market for Dapoxetine Hydrochloride 30mg Tablets 30mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
